Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis.

导出 LinkOut

翻译打印收藏纠错

作者： Kent Y,Feng ^[1] ; JingWei,Li ^[2] ; Juliana,Ianus ^[3] ; Dick,de Zeeuw ^[4] ; Greg R,Fulcher ^[5] ; Michael,Pfeifer ^[3] ; David R,Matthews ^[6] ; Meg J,Jardine ^[7] ; Vlado,Perkovic ^[2] ; Bruce,Neal ^[2] ; Kenneth W,Mahaffey ^[1]

作者单位： Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, California, USA. ^[1] George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia. ^[2] Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA. ^[3] University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. ^[4] Medicine, Royal North Shore Hospital and University of Sydney, Sydney, New South Wales, Australia. ^[5] Oxford Centre for Diabetes, Endocrinology and Metabolism and Harris Manchester College, University of Oxford, Oxford, UK. ^[6] NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. ^[7]

关键词 SGLT2 inhibitor canagliflozin cardiovascular outcomes hospitalization type 2 diabetes

主题词心血管系统(Cardiovascular System);糖尿病, 2型(Diabetes Mellitus, Type 2);住院(Hospitalization);人类(Humans);降血糖药(Hypoglycemic Agents)

DOI 10.1111/dom.14525

PMID 34402161

发布时间 2022-05-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交